Skip to main content
logo
Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
1.990
0.00 (0.00%)
At close: Jul 29, 2026, 4:00 PM EDT
2.019
+0.029 (1.45%)
After-hours: Jul 29, 2026, 5:26 PM EDT

Polaryx Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
3.085.144.620
Cash & Short-Term Investments
3.085.144.620
Cash Growth
-6.78%11.30%230950.00%-
Other Current Assets
0.420.030.382.31
Total Current Assets
3.55.1752.32
Total Assets
3.55.1752.32

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Accounts Payable
0.950.560.20.82
Accrued Expenses
0.070.040.090.09
Short-Term Debt
---0.13
Total Current Liabilities
1.010.610.291.04
Total Liabilities
1.010.610.291.04

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Common Stock
0.010.0100
Additional Paid-in Capital
104.66104.295.3661.57
Retained Earnings
-102.18-99.64-90.65-60.29
Shareholders' Equity
2.494.574.711.28
Total Liabilities & Equity
3.55.1752.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Total Debt
-000.13
Net Cash (Debt)
3.085.144.62-0.13
Net Cash Growth
-6.78%11.30%--
Net Cash Per Share
0.070.110.14-0.01
Book Value
2.494.574.711.28
Book Value Per Share
0.050.100.140.12
Tangible Book Value
2.494.574.711.28
Tangible Book Value Per Share
0.050.100.140.12
SEC Filings: 10-K · 10-Q